Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#209 most reported symptom for this vaccine
C-reactive protein increased has been reported 12 times in association with Influenza, Seasonal (Fluad Quadrivalent) vaccination in VAERS. This represents 0.3% of all 4,184 reports for this vaccine.
Among these reports, 1 mentioned death (8.33%) and 9 involved hospitalization (75.0%).
C-reactive protein increased is the #209 most frequently reported symptom for Influenza, Seasonal (Fluad Quadrivalent) out of 673 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 12 reports of C-reactive protein increased after Influenza, Seasonal (Fluad Quadrivalent) vaccination may seem alarming, but context is critical.
The 8.33% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.